Gabelli & Co Investment Advisers’s NeoGenomics NEO Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-20,000	Closed	-$161K	–	172
2016 Q2	$161K	Hold	20,000	–	–	0.02%	159
2016 Q1	$135K	Hold	20,000	–	–	0.02%	157
2015 Q4	$157K	Hold	20,000	–	–	0.02%	167
2015 Q3	$115K	Hold	20,000	–	–	0.02%	157
2015 Q2	$108K	Hold	20,000	–	–	0.02%	166
2015 Q1	$93K	Hold	20,000	–	–	0.02%	149
2014 Q4	$83K	Hold	20,000	–	–	0.01%	144
2014 Q3	$104K	Hold	20,000	–	–	0.02%	162
2014 Q2	$66K	Hold	20,000	–	–	0.01%	129
2014 Q1	$69K	Hold	20,000	–	–	0.02%	119
2013 Q4	$72K	Hold	20,000	–	–	0.03%	114
2013 Q3	$60K	Hold	20,000	–	–	0.01%	124
2013 Q2	$80K	Buy	+20,000	New	+$76.3K	0.02%	119

Other funds holding NEO

General Electric Evendale, Ohio $369M AUM 19.65% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Emerald Acquisition Seattle, Washington $51.8B AUM

CRC

Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Gabelli & Co Investment Advisers's NEO Position: Q3 2016 in Review

Gabelli & Co Investment Advisers sold out of NeoGenomics (NEO) in Q3 2016, closing a stake of 20,000 shares — an estimated $161K sold.

Gabelli & Co Investment Advisers first reported a position in NEO in Q2 2013 and held it in 13 quarters. The position peaked at $161K in Q2 2016. 137 funds tracked by Wall St. Rank hold NEO as of Q3 2016.

Gabelli & Co Investment Advisers reported no remaining NeoGenomics position as of Q3 2016 after selling out during the quarter.
Gabelli & Co Investment Advisers sold 20,000 NeoGenomics shares in Q3 2016, an estimated $161K.
Gabelli & Co Investment Advisers first reported a position in NeoGenomics in Q2 2013 and held it in 13 quarters.
Gabelli & Co Investment Advisers's NeoGenomics position peaked at $161K in Q2 2016.
137 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2016.

Based on Gabelli & Co Investment Advisers's 13F filing for Q3 2016, filed 14 Nov 2016.